AU2001256327A1 - Pneumovirus NS proteins antagonising the interferon (IFN) response - Google Patents
Pneumovirus NS proteins antagonising the interferon (IFN) responseInfo
- Publication number
- AU2001256327A1 AU2001256327A1 AU2001256327A AU2001256327A AU2001256327A1 AU 2001256327 A1 AU2001256327 A1 AU 2001256327A1 AU 2001256327 A AU2001256327 A AU 2001256327A AU 2001256327 A AU2001256327 A AU 2001256327A AU 2001256327 A1 AU2001256327 A1 AU 2001256327A1
- Authority
- AU
- Australia
- Prior art keywords
- antagonising
- pneumovirus
- ifn
- interferon
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000014150 Interferons Human genes 0.000 title 2
- 108010050904 Interferons Proteins 0.000 title 2
- 229940079322 interferon Drugs 0.000 title 2
- 241000711902 Pneumovirus Species 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10020505.4 | 2000-04-26 | ||
DE10020505A DE10020505A1 (en) | 2000-04-26 | 2000-04-26 | RSV NS proteins antagonize the interferon (IFN) response |
PCT/EP2001/004740 WO2001081554A1 (en) | 2000-04-26 | 2001-04-26 | Pneumovirus ns proteins antagonising the interferon (ifn) response |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001256327A1 true AU2001256327A1 (en) | 2002-01-24 |
AU2001256327B2 AU2001256327B2 (en) | 2005-06-09 |
Family
ID=7640025
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU5632701A Pending AU5632701A (en) | 2000-04-26 | 2001-04-26 | Pneumovirus ns proteins antagonising the interferon (ifn) response |
AU2001256327A Ceased AU2001256327B2 (en) | 2000-04-26 | 2001-04-26 | Pneumovirus ns proteins antagonising the interferon (ifn) response |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU5632701A Pending AU5632701A (en) | 2000-04-26 | 2001-04-26 | Pneumovirus ns proteins antagonising the interferon (ifn) response |
Country Status (17)
Country | Link |
---|---|
US (2) | US20030133911A1 (en) |
EP (1) | EP1276853B1 (en) |
JP (1) | JP2004504274A (en) |
KR (1) | KR100584831B1 (en) |
CN (1) | CN100473721C (en) |
AT (1) | ATE336570T1 (en) |
AU (2) | AU5632701A (en) |
BR (1) | BR0110384A (en) |
CA (1) | CA2407053A1 (en) |
CY (1) | CY1105704T1 (en) |
DE (2) | DE10020505A1 (en) |
DK (1) | DK1276853T3 (en) |
ES (1) | ES2271005T3 (en) |
IL (1) | IL152326A0 (en) |
MX (1) | MXPA02010465A (en) |
PT (1) | PT1276853E (en) |
WO (1) | WO2001081554A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2400445T3 (en) | 1998-06-12 | 2013-04-09 | Mount Sinai School Of Medicine | Attenuated viruses with negative polarity chain with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
AU2001257001A1 (en) | 2000-04-10 | 2001-10-23 | Mount Sinai School Of Medicine Of New York University | Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents |
WO2006083286A2 (en) | 2004-06-01 | 2006-08-10 | Mount Sinai School Of Medicine Of New York University | Genetically engineered swine influenza virus and uses thereof |
EP1855713B1 (en) | 2005-02-15 | 2016-04-27 | Mount Sinai School of Medicine | Genetically engineered equine influenza virus and uses thereof |
CN102089423A (en) * | 2007-08-31 | 2011-06-08 | Aeras全球Tb疫苗基金会 | Enhancement of transgene expression from viral-based vaccine vecors by expression of suppressors of the type i interferon response |
CN102021149B (en) * | 2010-07-27 | 2013-04-24 | 张卫东 | Gene NSI deficit type respiratory syncytial virus and application thereof in treating lung cancer |
MX2017010908A (en) | 2015-02-26 | 2017-12-07 | Boehringer Ingelheim Vetmedica Gmbh | Bivalent swine influenza virus vaccine. |
US10947512B2 (en) | 2015-08-14 | 2021-03-16 | Research Institute At Nationwide Children's Hospital | Respiratory syncytial virus having altered NS1 protein function and related materials and methods |
CN111214495B (en) * | 2020-03-02 | 2021-12-31 | 广西医科大学第一附属医院 | Application of mycobacterium vaccae for injection in preparation of medicine for preventing and treating respiratory system RSV infection |
WO2024102703A2 (en) * | 2022-11-07 | 2024-05-16 | The Regents Of The University Of California | Zikv-based gene delivery system |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6923971B2 (en) * | 1995-09-27 | 2005-08-02 | The United States Of America As Represented By The Department Of Health & Human Services | Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes |
AU7719596A (en) * | 1995-11-07 | 1997-05-29 | Baylor College Of Medicine | Adenovirus-mediated production of bioactive proteins by mammalian cells and animals |
BR9710363A (en) * | 1996-07-15 | 2000-01-11 | Us Gov Health & Human Serv | "Isolated infectious recombinant respiratory syncytial virus, particulate, processes to stimulate an individual's immune system to induce protection against respiratory syncytial virus and to produce a particle of recombinant respiratory syncytial virus, vaccine to induce protection against recombinant respiratory syncytial virus. composition and collection of recombinant respiratory syncytial virus " |
US6699476B1 (en) * | 1996-07-15 | 2004-03-02 | Peter L. Collins | Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
US6844188B1 (en) * | 1998-04-08 | 2005-01-18 | University Of North Carolina At Chapel Hill | Methods and modified cells for the treatment of cancer |
ES2400445T3 (en) * | 1998-06-12 | 2013-04-09 | Mount Sinai School Of Medicine | Attenuated viruses with negative polarity chain with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
AU2002368225A1 (en) * | 2001-10-10 | 2004-05-04 | Mount Sinai School Of Medicine Of The City University Of New York | Viral interferon antagonists and uses therefor |
-
2000
- 2000-04-26 DE DE10020505A patent/DE10020505A1/en not_active Withdrawn
-
2001
- 2001-04-26 WO PCT/EP2001/004740 patent/WO2001081554A1/en active IP Right Grant
- 2001-04-26 KR KR1020027014395A patent/KR100584831B1/en not_active IP Right Cessation
- 2001-04-26 EP EP01929607A patent/EP1276853B1/en not_active Expired - Lifetime
- 2001-04-26 AU AU5632701A patent/AU5632701A/en active Pending
- 2001-04-26 ES ES01929607T patent/ES2271005T3/en not_active Expired - Lifetime
- 2001-04-26 AU AU2001256327A patent/AU2001256327B2/en not_active Ceased
- 2001-04-26 IL IL15232601A patent/IL152326A0/en unknown
- 2001-04-26 DK DK01929607T patent/DK1276853T3/en active
- 2001-04-26 CA CA002407053A patent/CA2407053A1/en not_active Abandoned
- 2001-04-26 US US10/258,825 patent/US20030133911A1/en not_active Abandoned
- 2001-04-26 BR BR0110384-9A patent/BR0110384A/en not_active Application Discontinuation
- 2001-04-26 DE DE50110752T patent/DE50110752D1/en not_active Expired - Lifetime
- 2001-04-26 AT AT01929607T patent/ATE336570T1/en not_active IP Right Cessation
- 2001-04-26 PT PT01929607T patent/PT1276853E/en unknown
- 2001-04-26 CN CNB018087760A patent/CN100473721C/en not_active Expired - Fee Related
- 2001-04-26 MX MXPA02010465A patent/MXPA02010465A/en active IP Right Grant
- 2001-04-26 JP JP2001578625A patent/JP2004504274A/en active Pending
-
2006
- 2006-10-13 CY CY20061101472T patent/CY1105704T1/en unknown
-
2007
- 2007-07-24 US US11/880,914 patent/US7700092B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002306269A1 (en) | N-arylphenylacetamide derivatives and pharmaceutical composition containing the same | |
AU2705201A (en) | Ceramic structure | |
AU2001232799A1 (en) | Protein c derivatives | |
AU2001252557A1 (en) | Adhesive for circuit connection, circuit connection method using the same, and circuit connection structure | |
AU2002353921A1 (en) | Proteins stabilized with polysaccharide gums | |
AU2002310502A1 (en) | In vitro protein interaction detection systems | |
AU2001256327A1 (en) | Pneumovirus NS proteins antagonising the interferon (IFN) response | |
AU2002215336A1 (en) | Pollucite-based ceramic with low cte | |
AU6405500A (en) | Improved mass flow sensor interface circuit | |
AU2001240018A1 (en) | Adeno-associated viral compositions and methods | |
AU2001276258A1 (en) | Ceramic component and the use thereof | |
AU2002368225A1 (en) | Viral interferon antagonists and uses therefor | |
AU2001252671A1 (en) | Pyridobenzodiazine derivatives and processes for the preparation thereof | |
AU2001253481A1 (en) | Methods and compositions for eleciting an immune response | |
AU2001295859A1 (en) | Isoprenoid-dependent ras anchorage (idra) proteins | |
AU2002239747A1 (en) | Cystoskeleton-associated proteins | |
AU2002334631A1 (en) | Immune response associated proteins | |
AU2001280993A1 (en) | Tissue-associated proteins and their uses | |
AU2002361550A1 (en) | Keratinocyte derived interferon | |
AU2002357850A1 (en) | Neurotransmission-associated proteins | |
AU2001241044A1 (en) | Mitf-associated proteins | |
AU2001269395A1 (en) | An electronic mail system | |
AU2001292077A1 (en) | Cytokine proteins | |
AU2002220838A1 (en) | Cytokine proteins | |
AU2002227989A1 (en) | Component measures |